"
Home Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Page43 Page44 Page45 Page46 Page47 Page48 Page49 Page50 Page51 Page52 Page53 Page54 Page55 Page56 Page57 Page58 Page59 Page60 Page61 Page62 Page63 Page64 Page65 Page66 Page67 Page68 Page69 Page70 Page71 Page72 Page73 Page74 Page75 Page76 Page77 Page78 Page79 Page80 Page81 Page82 Page83 Page84 Page85 Page86 Page87 Page88 Page89 Page90 Page91 Page92 Page93 Page94 Page95 Page96 Page97 Page98 Page99 Page100 Page101 Page102 Page103 Page104 Page105 Page106 Page107 Page108 Page109 Page110 Page111 Page112 Page113 Page114 Page115 Page116 Page117 Page118 Page119 Page120 Page121 Page122 Page123 Page124 Page125 Page126 Page127 Page128 Page129 Page130 Page131

Second Messengers in Cellular Signaling

Second messengers are essential intracellular molecules that convey signals from extracellular ligands, such as hormones and neurotransmitters, to intracellular targets. They amplify and regulate key cellular processes including metabolism, growth, and neural transmission.


1. Cyclic AMP (cAMP)

Synthesis and Degradation

  • Synthesis: Formed from ATP by adenylyl cyclase, typically triggered by G-protein-coupled receptor (GPCR) activation.
  • Degradation: Broken down to AMP by phosphodiesterases (PDEs).

Physiological Role

  • Regulates cardiac contraction, glycogen metabolism, and hormonal responses.

Pathophysiological Importance

  • Abnormal levels contribute to heart failure, asthma, and metabolic disorders.

Drugs Modulating cAMP

  • Beta-agonists: Increase cAMP in asthma (e.g., albuterol).
  • PDE inhibitors: Prevent cAMP degradation, used in asthma and heart failure (e.g., theophylline, milrinone).

2. Cyclic GMP (cGMP)

Synthesis and Degradation

  • Synthesis: Produced from GTP by guanylyl cyclase, activated by nitric oxide or natriuretic peptides.
  • Degradation: PDE5 degrades cGMP.

Physiological Role

  • Involved in vasodilation, muscle relaxation, vision, and platelet aggregation.

Pathophysiological Importance

  • Imbalances contribute to hypertension, erectile dysfunction, and retinal diseases.

Drugs Modulating cGMP

  • PDE5 inhibitors: Treat erectile dysfunction (e.g., sildenafil).
  • Nitroglycerin: Increases cGMP for angina treatment.

3. Calcium Ions (Ca²⁺)

Source

  • Released from the endoplasmic reticulum via IP₃ receptors or voltage-gated channels.

Physiological Role

  • Controls muscle contraction, neurotransmitter release, and gene expression.

Pathophysiological Importance

  • Abnormal levels linked to arrhythmias, neurodegeneration, and osteoporosis.

Drugs Modulating Ca²⁺

  • Calcium channel blockers: Used in hypertension and arrhythmias (e.g., amlodipine).
  • Calcimimetics: Used in hyperparathyroidism.

4. Inositol Triphosphate (IP₃) and Diacylglycerol (DAG)

Synthesis

  • Formed from phospholipase C cleavage of PIP₂ upon GPCR activation.

Physiological Role

  • IP₃ triggers Ca²⁺ release; DAG activates PKC, regulating cell growth and secretion.

Pathophysiological Importance

  • Linked to cancer, immune dysfunction, and psychiatric disorders.

Drugs Modulating IP₃/DAG

  • Lithium: Reduces IP₃ signaling, used in bipolar disorder.

5. Nitric Oxide (NO)

Synthesis

  • Produced from L-arginine by nitric oxide synthase, often triggered by calcium influx.

Physiological Role

  • Functions as a vasodilator, neurotransmitter, and immune regulator.

Pathophysiological Importance

  • Dysregulation contributes to hypertension and atherosclerosis.

Drugs Modulating NO

  • Nitroglycerin: Increases NO for angina treatment.

Clinical Importance of Modulating Second Messengers

Modulating second messengers offers targeted therapeutic interventions, adjusting physiological processes to manage conditions in cardiovascular, respiratory, and nervous system disorders. For example, enhancing cAMP levels in asthma or cGMP for erectile dysfunction contributes significantly to patient health outcomes.


© 2024 Easy Notes on Pharmacology.
Privacy Policy | Contact Us Subscribe to our RSS feed